article thumbnail

Arcturis and Oxford University Hospitals NHS Foundation Trust announce 3-year programme to deliver highly enriched Real-World Data supporting generation of evidence for the development and approval of novel cancer therapies.

Digital Health Global

The programme of works builds on the success of Arcturis and OUH’s long-standing multi-disease strategic research partnership, and represents significant innovation at the convergence of technology, informatics, pharmaceutical research, and clinical excellence.

article thumbnail

How have Healthcare ICO’s performed in the last 5 years?

Lloyd Price

However, the regulatory environment for healthcare ICOs is still evolving, and there is a risk that some ICOs could face legal challenges. Here are some examples of successful healthcare ICOs: Ambrosus is a blockchain-based platform that tracks the provenance of food and pharmaceuticals.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Tech-enabled healthcare: What exactly is it? Funding, IPO's and Future Trends

Lloyd Price

A surgeon can use AI-assisted surgery to improve the accuracy and precision of their work. A pharmaceutical company can use AI to develop new drugs and treatments more quickly and efficiently. A patient in a rural area can use telehealth to consult with a specialist without having to travel to a major city.

article thumbnail

Health informatics and why participatory healthcare is key to its future

Society for Participatory Medicine

In order to advance healthcare, improve efficiency and care coordination, and make it easier for health information to be shared between different covered entities, electronic health records needed to be adopted. We are working with the leadership of SPM to develop a course on participatory healthcare and its enabling technologies.

article thumbnail

Lyfegen Raises $8 Million to Drive Down Drug Costs and Help Patients Access Life-Saving Medications

Healthcare IT Today

As a result, value-based contracting is becoming a more viable alternative for healthcare payers to only pay for drugs that actually work. Additionally, new drugs regularly enter the market, but when pharmaceutical companies fail to agree on commercial terms with payers, patients are at risk of being denied access to life saving therapies.